TSH antibodies for point-of-care immunoassay formats
US9575077B2 · kind B2 · utility
0Cited by
14References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 30, 2015 |
| Grant date | Feb 21, 2017 |
| Priority date | — |
| Expiry date | Oct 30, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/59
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The invention relates to antibody characteristics used to design a whole blood Point of Care Thyroid Stimulating Hormone (TSH) immunoassay using an ELISA sandwich assay lacking one or more wash steps between the antigen capture, detection antibody addition and substrate introduction steps. This invention exhibits low cross reactivity with biologically similar interfering cross reacting species, such as Follicle Stimulating Hormone (FSH), Luteinizing Hormone (LH) and Chorionic Gonadotropin (CG).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.